id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2473371,a1ca9b4c-6f5d-4ece-a3ae-ffc3ec4fa4eb,Q2,U.S. PUBLIC INTEREST RESEARCH GROUP,38814,U.S. PUBLIC INTEREST RESEARCH GROUP,2020,second_quarter,CSP,"Opposed anti- Right to Repair provisions in the National Defense Authorization Act in the Senate.

Urged leadership of Senate Commerce Committee not to schedule a confirmation vote on and more generally to oppose the nomination of former chemical industry lobbyist Nancy Beck to chair the U.S. Consumer Product Safety Commission. Conducted general outreach activities to Congress on this matter.

Joined coalition letter to FTC urging it to withhold final consent to the merger of prescription drug companies Abbvie and Allergan (AbbVie and Allergan; File No. 191 0169).

Submitted group comment to US DOT on Defining Unfair or Deceptive Practices in Airlines and Ticketing Agents, Docket No. DOT-OST-2019-0182.

Sent civil society letter to House Judiciary Committee leaders opposing efforts by U.S. Chamber of Commerce to demand sweeping business immunity from COVID19-related claims by consumers or workers.

Sent consumer group letter to Congressional leaders opposing efforts by U.S. Chamber of Commerce to demand sweeping business immunity from COVID19-related claims by consumers or workers.

Sent civil society letter to Congressional leaders opposing efforts by U.S. Chamber of Commerce to demand sweeping business immunity from COVID19-related claims by consumers or workers.","Consumer Product Safety Commission (CPSC),Federal Deposit Insurance Corporation (FDIC),Federal Reserve System,Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of the Comptroller of the Currency (OCC),SENATE,Transportation, Dept of (DOT),Treasury, Dept of",,10000,0,0,2020-07-17T15:32:07.683000-04:00